TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Spago Nanomedical AB (publ)
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 95 | 65 | 34 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -3,522 | -3,820 | -1,886 |
EBITDA | -3,514 | -3,795 | -1,853 |
Total assets | 18,507 | 18,737 | 16,221 |
Current assets | 5,863 | 5,318 | 2,972 |
Current liabilities | 791 | 666 | 313 |
Equity capital | 17,717 | 18,071 | 15,908 |
- share capital | 8,172 | 4,027 | 2,095 |
Employees (average) | 15 | 16 | 15 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 95.7% | 96.4% | 98.1% |
Turnover per employee | 6 | 4 | 2 |
Profit as a percentage of turnover | -3707.4% | -5876.9% | -5547.1% |
Return on assets (ROA) | -19.0% | -20.4% | -11.6% |
Current ratio | 741.2% | 798.5% | 949.5% |
Return on equity (ROE) | -19.9% | -21.1% | -11.9% |
Change turnover | 35 | 31 | 31 |
Change turnover % | 60% | 93% | 1040% |
Chg. No. of employees | -1 | 1 | -2 |
Chg. No. of employees % | -6% | 7% | -12% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.